BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer

被引:19
|
作者
Erturk, Elif [1 ]
Cecener, Gulsah [2 ]
Tezcan, Gulcin [2 ,3 ]
Egeli, Unal [2 ]
Tunca, Berrin [2 ]
Gokgoz, Sehsuvar [4 ]
Tolunay, Sahsine [5 ]
Tasdelen, Ismet [4 ]
机构
[1] Uludag Univ, Vocat Sch Hlth Serv, Bursa, Turkey
[2] Uludag Univ, Dept Med Biol, Fac Med, Bursa, Turkey
[3] Uludag Univ, Inst Hlth Sci, Dept Med Biol, Bursa, Turkey
[4] Uludag Univ, Dept Gen Surg, Fac Med, Bursa, Turkey
[5] Uludag Univ, Dept Pathol, Fac Med, Bursa, Turkey
关键词
Triple negative breast cancer; MicroRNA; BRCA1/2 gene mutations; miR-200c; EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; OVARIAN-CANCER; FEEDBACK LOOP; FAMILY; ZEB1; MICRORNA-200C; PROGRESSION; METASTASIS; RESISTANCE;
D O I
10.1016/j.gene.2014.11.047
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Triple negative breast cancer (TNBC) is the most aggressive and poorly understood subclass of breast cancer (BC). Over the recent years, miRNA expression studies have been providing certain detailed overview that aberrant expression of miRNAs is associated with TNBC. Although TNBC tumors are strongly connected with loss of function of BRCA genes, there is no knowledge about the effect of BRCA mutation status on miRNA expressions in TNBC cases. The aims of this study were to evaluate the expression profile of miRNAs that plays role in TNBC progression and the role of BRCA mutations in their regulation. The expression level of BC associated 13 miRNAs was analyzed in 7 BRCA mutations positive, 6 BRCA mutations negative TNBC cases and 20 non-tumoral tissues using RT-PCR. According to RT2 Profiler PCR Array Data Analysis, let-7a expression was 4.67 fold reduced in TNBCs as compared to normal tissues (P = 0.031). In addition, miR-200c expression was 5.75 fold reduced in BRCA mutation positive TNBC tumors (P = 0.005). Analysis revealed a negative correlation between miR-200c and VEGFA expressions (r = -468). Thus, miR-200c may be involved in invasion and metastasis in TNBC cases with BRCA mutation. In this study we provide the knowledge on the first report of association between microRNA-200c and BRCA mutations in TNBC. Further studies and evaluations are required, but this miRNA may provide novel therapeutic molecular targets for TNBC treatment and new directions for the development of anticancer drugs. (C) 2014 Published by Elsevier B.V.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 50 条
  • [31] Outcome of Triple Negative Breast Cancer in Patients with or without Deleterious BRCA Mutations
    Arun, B. K.
    Gutierrez-Barrera, A. M.
    Akar, U.
    Litton, J. K.
    Albarracin, C.
    Gonzalez-Angulo, A. M.
    Hortobagyi, G. N.
    CANCER RESEARCH, 2010, 70
  • [32] Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer
    Hartman, Anne-Renee
    Kaldate, Rajesh R.
    Sailer, Lisa M.
    Painter, Lisa
    Grier, Charles E.
    Endsley, Robbin R.
    Griffin, Marlena
    Hamilton, Stephanie A.
    Frye, Cynthia A.
    Silberman, Mark A.
    Wenstrup, Richard J.
    Sandbach, John F.
    CANCER, 2012, 118 (11) : 2787 - 2795
  • [33] The Role of miR-200c Decorated Liposomal Nanoparticles as a Carrier Target for Wnt/β-Catenin Signaling to Regulate Triple-Negative Breast Cancer Cell Line
    Fang, Ping
    Peng, Liang
    Wang, Hangzheng
    Zhang, Xin
    SCIENCE OF ADVANCED MATERIALS, 2021, 13 (09) : 1622 - 1628
  • [34] MiR-200c reprograms fibroblasts to recapitulate the phenotype of CAFs in breast cancer progression
    Lin, Zhao
    Roche, Megan E.
    Diaz-Barros, Victor
    Domingo-Vidal, Marina
    Whitaker-Menezes, Diana
    Tuluc, Madalina
    Uppal, Guldeep
    Caro, Jaime
    Curry, Joseph M.
    Martinez-Outschoorn, Ubaldo
    CELL STRESS, 2024, 8 (01) : 1 - 20
  • [35] Use of Gene Expression Markers To Screen for BRCA-1 Germline Mutations in Triple Negative Breast Cancer
    Swanson, E. A.
    Li, X.
    Sullivan, P. S.
    Moatamed, N. A.
    Apple, S. K.
    MODERN PATHOLOGY, 2012, 25 : 69A - 70A
  • [36] Use of Gene Expression Markers To Screen for BRCA-1 Germline Mutations in Triple Negative Breast Cancer
    Swanson, E. A.
    Li, X.
    Sullivan, P. S.
    Moatamed, N. A.
    Apple, S. K.
    LABORATORY INVESTIGATION, 2012, 92 : 69A - 70A
  • [37] Decreased expression of VLDLR is inversely correlated with miR-200c in human colorectal cancer
    Kim, Bong-Kyu
    Yoo, Hye-In
    Lee, Ah-Reum
    Choi, Keonwoo
    Yoon, Sungjoo Kim
    MOLECULAR CARCINOGENESIS, 2017, 56 (06) : 1620 - 1629
  • [38] miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
    Kopp, Florian
    Oak, Prajakta S.
    Wagner, Ernst
    Roidl, Andreas
    PLOS ONE, 2012, 7 (11):
  • [39] PARP Inhibitors in Triple-Negative Breast Cancer Including Those With BRCA Mutations
    Layman, Rachel M.
    Arun, Banu
    CANCER JOURNAL, 2021, 27 (01): : 67 - 75
  • [40] Are Triple Negative Breast Cancer Patients Screened for BRCA Mutations According to NCCN Guidelines?
    Petersen, L.
    Aubry, S.
    Burgess, K.
    Rao, R.
    Kopkash, K.
    Madrigrano, A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S67 - S68